tiprankstipranks
Grace Therapeutics (GRCE)
NASDAQ:GRCE
US Market
GRCE
Grace Therapeutics
RESEARCH TOOLSreports
Want to see GRCE full AI Analyst Report?

Grace Therapeutics (GRCE) Financial Statements

1,205 Followers

Grace Therapeutics Financial Overview

Grace Therapeutics's market cap is currently $35.59M. The company's EPS TTM is $-0.4975; its P/E ratio is -4.57; Grace Therapeutics is scheduled to report earnings on February 12, 2026, and the estimated EPS forecast is $-0.23. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 309.32K
Gross ProfitC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 189.38K
Operating IncomeC$ -23.75MC$ -17.44MC$ -70.54MC$ -19.48MC$ -25.91M
EBITDAC$ -23.74MC$ -15.37MC$ -24.51MC$ -19.17MC$ -15.45M
Net IncomeC$ -13.63MC$ -17.44MC$ -57.39MC$ -12.27MC$ -31.05M
Balance Sheet
Cash & Short-Term InvestmentsC$ 22.13MC$ 23.00MC$ 27.89MC$ 43.66MC$ 76.29M
Total AssetsC$ 71.99MC$ 73.30MC$ 79.12MC$ 128.62MC$ 78.46M
Total DebtC$ 0.00C$ 0.00C$ 485.00KC$ 295.00KC$ 108.04K
Net DebtC$ -22.13MC$ -23.00MC$ -27.39MC$ -30.04MC$ -63.89M
Total LiabilitiesC$ 5.38MC$ 11.56MC$ 11.17MC$ 20.35MC$ 8.54M
Stockholders' EquityC$ 66.61MC$ 61.74MC$ 67.95MC$ 108.27MC$ 69.92M
Cash Flow
Free Cash FlowC$ -14.90MC$ -12.36MC$ -15.93MC$ -17.23MC$ -18.07M
Operating Cash FlowC$ -14.90MC$ -12.33MC$ -15.91MC$ -17.23MC$ -17.99M
Investing Cash FlowC$ 0.00C$ 104.00KC$ 13.15MC$ -3.52MC$ -12.38M
Financing Cash FlowC$ 14.03MC$ 7.36MC$ 304.00KC$ 0.00C$ 74.73M
Currency in CAD

Grace Therapeutics Earnings and Revenue History

Income Statement >

Grace Therapeutics Debt to Assets

Balance Sheet >

Grace Therapeutics Cash Flow

Cash Flow >

Grace Therapeutics Forecast EPS vs Actual EPS

Earnings >